尿液生化检测揭示2型糖尿病年度复查者心血管药物依从性低
该研究采用液相色谱-串联质谱法(LC-MS/MS)检测228例基层2型糖尿病患者的常规尿液样本,评估心血管药物依从性。结果显示28.1%患者对降糖、降压和/或降脂药物不依从,他汀类不依从率最高达23.7%,口服降糖药为9.3%。不依从者HbA1c、白蛋白与肌酐比值及血脂水平显著高于依从者。
要点
- 常规尿液LC-MS/MS可客观筛查2型糖尿病患者的药物不依从性。
- 他汀类不依从率最高(23.7%),口服降糖药为9.3%。
- 不依从者血糖、蛋白尿及血脂控制更差。
核心结论
- 常规尿液样本可用于LC-MS/MS依从性筛查,2型糖尿病患者不依从率较高,尤其他汀类。
研究设计与样本
- 研究纳入基层228例2型糖尿病患者的年度复查常规尿液样本,采用LC-MS/MS检测药物依从性。
主要发现
- 28.1%患者(N=64)对降糖、降压和/或降脂药物不依从。
- 他汀类不依从率最高为23.7%,口服降糖药不依从率为9.3%。
- 不依从者HbA1c、白蛋白与肌酐比值及血脂谱显著高于依从者。
临床怎么用
- 可考虑将常规尿液LC-MS/MS作为客观评估心血管药物依从性的筛查工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a new method to objectively and robustly detect nonadherence. We applied this technique to study nonadherence to cardiovascular medications in people with type 2 diabetes (T2DM). RESEARCH DESIGN AND METHODS: Routine urine samples, received at the time of the annual diabetes review from 228 people with T2DM in primary care, were assessed for adherence by LC-MS/MS. RESULTS: A total of 28.1% patients (N = 64) were nonadherent to antidiabetic, antihypertensive, and/or lipid-lowering medications. Nonadherence to statins was the highest at 23.7%, and nonadherence to oral hypoglycemic agents was 9.3%. HbA1c, albumin-to-creatinine ratio, and lipid profiles were significantly higher in the patients who were nonadherent compared with those who were adherent to treatment. CONCLUSIONS: This unique study shows that routine urine samples can be used for adherence testing screening by LC-MS/MS and has demonstrated high nonadherence rates especially to statins in people with T2DM. Future intervention studies using LC-MS/MS as a diagnostic/therapeutic tool may help to improve clinical outcomes.
引用
- Patel P, Gupta P, Burns A, et al. Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes. Diabetes Care. 2019. PMID: 30885952. doi:10.2337/dc18-1453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。